PS
Priya Singhal
Head of Development

Priya Singhal insider trades: Biogen (BIIB) stock sales

Head of Development, Biogen Last trade Feb 9, 2026 28 Form 4 filings
$666K
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
16
Open-market trades
since 2023
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Priya reports to the SEC

Open-market buys and sales

16 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 9, 2026BIIB↓ Sell$532K
Feb 2, 2026BIIB↓ Sell$134K
Sep 2, 2025BIIB↓ Sell$69K
May 19, 2025BIIB↓ Sell$481K
Dec 9, 2024BIIB↓ Sell$17K
Sep 3, 2024BIIB↓ Sell$88K
Apr 2, 2024BIIB↓ Sell$20K
Feb 22, 2024BIIB↓ Sell$58K
Feb 16, 2024BIIB↓ Sell$24K
Feb 12, 2024BIIB↓ Sell$100K
Feb 2, 2024BIIB↓ Sell$156K
Dec 11, 2023BIIB↓ Sell$27K
Sep 5, 2023BIIB↓ Sell$116K
Jul 3, 2023BIIB↓ Sell$23K
Apr 4, 2023BIIB↓ Sell$25K
Mar 28, 2023BIIB↓ Sell$153K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BIIB insiders

Open-market trades in the last 12 months

About Priya Singhal's insider trades

Priya Singhal is Head of Development at Biogen (BIIB). Since Mar 28, 2023, Priya has reported no open-market purchases and 16 sales worth $2.0M on SEC Form 4. In the last 12 months: 2 sales ($666K).

Their filings also include option exercises (17 filings), shares withheld for taxes (17 filings), grants and awards (7 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BIIB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.